Status | Study |
Terminated |
Study Name: Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2013-09-24 Interventions: Biological: Trichuris suis ova (TSO) |
Active, not recruiting |
Study Name: A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2013-07-12 Interventions: Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg |
Completed |
Study Name: A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis. Condition: Colitis, Ulcerative Date: 2013-05-23 Interventions: Drug: Golimumab Participants w |
Withdrawn |
Study Name: A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2012-05-24 Interventions: Drug: GSK1605786 500 mg twice |
Completed |
Study Name: The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients Condition: Colitis, Ulcerative Date: 2011-12-12 Interventions: Drug: Kappaproct 30 mg rectal |
Completed |
Study Name: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients Condition: Colitis, Ulcerative Date: 2011-01-25 Interventions: Biological: Anrukinzumab 200 m |
Completed |
Study Name: A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2010-11-10 Interventions: Drug: placebo once every 7 day |
Completed |
Study Name: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2009-12-17 Interventions: Drug: GSK1399686 Each dose level of GSK1399686 will be subsequently tested in a cohort of approximately |
Terminated |
Study Name: Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2008-09-05 Interventions: Drug: SB-656933 7 days repeat dose Other Name: SB656 |
Completed |
Study Name: Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) Condition: Colitis, Ulcerative Date: 2008-09-03 Interventions: Drug: budesonide 3x 3mg budeso |